無料プレビュー

Corcept Therapeutics Incorporated (CORT) · NASDAQ Capital Market

プロフィール

Corcept Therapeutics is a commercial-stage pharmaceutical company that discovers and develops selective cortisol-modulating medications for endocrinologic, oncologic, metabolic and neurologic disorders. The company markets Korlym (mifepristone) and an authorized generic version in the United States for hypercortisolism treatment, and is advancing proprietary cortisol modulators including relacorilant, nenocorilant, miricorilant and dazucorilant through clinical trials for hypercortisolism, solid tumors (ovarian, endometrial, cervical, pancreatic and prostate cancers), metabolic dysfunction-ass

主要指標

株価: $118.54 (-0.89%)
時価総額: 128億ドル
PER（今期予想）: 57.5
PBR: 17.7
配当利回り: —
52週レンジ: $28.66 – $126.38
業種: Healthcare / Medical - Pharmaceuticals
上場: NASDAQ Capital Market
構成銘柄: —

比較会社: RPRX Royalty Pharma plc、WBA Walgreens Boots Alliance, Inc.、KNSA Kiniksa Pharmaceuticals International, plc、MBX MBX Biosciences, Inc. Common Stock、LQDA Liquidia Corporation、PBH Prestige Consumer Healthcare Inc.、LTGO Latigo Biotherapeutics Inc.、HELP Helus Pharma Inc.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-04 · 更新: 2026-10-09